- Home
- CSBR vs CCIF Comparison
CSBR vs CCIF Comparison
Compare CSBR & CCIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- CCIF
- Stock Information
- Founded
- CSBR 1985
- CCIF 2011
- Country
- CSBR United States
- CCIF United States
- Employees
- CSBR N/A
- CCIF N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- CCIF Finance/Investors Services
- Sector
- CSBR Health Care
- CCIF Finance
- Exchange
- CSBR Nasdaq
- CCIF Nasdaq
- Market Cap
- CSBR 123.2M
- CCIF 121.4M
- IPO Year
- CSBR 1986
- CCIF N/A
- Fundamental
- Price
- CSBR $8.30
- CCIF $5.80
- Analyst Decision
- CSBR Strong Buy
- CCIF
- Analyst Count
- CSBR 1
- CCIF 0
- Target Price
- CSBR $12.00
- CCIF N/A
- AVG Volume (30 Days)
- CSBR 30.4K
- CCIF 76.9K
- Earning Date
- CSBR 09-15-2025
- CCIF 01-01-0001
- Dividend Yield
- CSBR N/A
- CCIF 25.90%
- EPS Growth
- CSBR N/A
- CCIF N/A
- EPS
- CSBR 0.33
- CCIF N/A
- Revenue
- CSBR $56,944,000.00
- CCIF N/A
- Revenue This Year
- CSBR $9.30
- CCIF N/A
- Revenue Next Year
- CSBR $31.17
- CCIF N/A
- P/E Ratio
- CSBR $24.12
- CCIF N/A
- Revenue Growth
- CSBR 13.54
- CCIF N/A
- 52 Week Low
- CSBR $3.75
- CCIF $7.43
- 52 Week High
- CSBR $11.99
- CCIF $10.16
- Technical
- Relative Strength Index (RSI)
- CSBR 68.02
- CCIF 55.21
- Support Level
- CSBR $6.33
- CCIF $5.47
- Resistance Level
- CSBR $7.25
- CCIF $5.80
- Average True Range (ATR)
- CSBR 0.40
- CCIF 0.12
- MACD
- CSBR 0.09
- CCIF 0.03
- Stochastic Oscillator
- CSBR 81.74
- CCIF 84.62
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest
Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing predominantly in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting mainly of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.